Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

ImaRx Therapeutics completes its IPO

Executive Summary

After withdrawing its filing last year, ImaRx Therapeutics (pharmaceuticals for cardiovascular conditions) has now gone public through an IPO netting $12.3mm through the sale of 3mm common shares at $5 each; the company originally estimated a share price in the $6.50-7.50 range.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register